The low-grade lymphoproliferative disorders.
Rapid advances in our understanding of the biology and pathology of lymphoproliferative disorders, permitted mainly by new diagnostic tools, constantly change our approach to this heterogenous group of disorders. In this review of the more indolent subgroup of lymphoproliferative disorders, some of the recent advances are highlighted, and treatment options discussed.
Eek
R
R
Department of Medical Oncology, University of Pretoria, South Africa.
Falkson
G
G
D006801:Humans; D016130:Immunophenotyping; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000628:therapy; D008232:Lymphoproliferative Disorders / Q000145:classification / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis